Related Experiment Videos
[NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from the human term placenta]
Nihon Sanka Fujinka Gakkai Zasshi
|April 1, 1987
Summary
Researchers purified a key enzyme, NAD+-dependent 15-hydroxyprostaglandin dehydrogenase, from human placenta. Electrophoretic analysis revealed a labile oligomeric structure, challenging previous monomeric theories and explaining enzyme instability.
Area of Science:
- Biochemistry
- Enzymology
Context:
- Prostaglandins play crucial roles in various physiological processes.
- NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) is vital for prostaglandin metabolism.
- Understanding the structure and stability of 15-PGDH is essential for its functional characterization.
Purpose:
- To purify and characterize human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
- To investigate the molecular structure and stability of the purified enzyme.
- To reconcile conflicting data regarding the enzyme's quaternary structure.
Summary:
- Human term placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase was purified using monoclonal antibody affinity chromatography, achieving a 4,800-fold purification.
- Gel filtration indicated a molecular weight of 49,000, while SDS-PAGE revealed subunits of 28-30 kDa and 52-56 kDa.
- Electrophoretic analyses suggest a labile oligomeric structure, contrasting with prior monomeric enzyme theories and potentially explaining observed activity instability.
Impact:
- Provides a highly purified enzyme preparation for further biochemical studies.
- Challenges existing models of 15-PGDH structure, suggesting a more complex oligomeric form.
- Offers insights into enzyme instability, crucial for understanding its physiological regulation and potential therapeutic applications.